Albumin Market – Overview of Key Market Forces and Market Growth

Appropriate selection of excipients during the new product development is one of the critical in the pharmaceutical formulations. Criteria for selection of suitable excipient depend on the physical, chemical and biological properties of the excipient. Primarily, it should help stabilize and protect the drug/active pharmaceutical ingredient (API) in the formulation against degradation, oxidation or aggregation, during manufacturing, transport and storage. Preformulation studies comprise investigation of drug-excipient interactions that help in selection of appropriate excipients to achieve the desired properties for the final drug product. Albumin is a well characterized protein and functions as a therapeutic, diagnostic agent, as well as an excipient. As an excipient, albumin has wide applications in drug formulation, drug delivery, vaccine manufacturing and as a component of media in vaccine production. Stable nature of albumin makes its handling and storage easier than other proteins, making it suitable for use as an excipient. Albumin due to its intrinsic stability can be heated at 60°C for 10 hours facilitating virus inactivation during manufacturing.

Read Complete Report @

This report studies the global market for albumin encompassing type, applications and geography. Types of albumin include human serum albumin, bovine serum albumin and recombinant albumin. Major applications for albumin as an excipient comprise drug formulation and drug delivery, vaccines and component of medium. Each of these segments has been analyzed in detail from market trends and recent developments to future outlook and opportunities. The report provides the albumin market size in terms of value (USD million) and volume (kg) for each segment and sub-segment for the period from 2012 to 2020, considering the macro- and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall albumin market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 as historical year and 2013 as the base year. The global albumin market report also includes an elaborate executive summary, which covers a market snapshot representing key findings from the study.

Inquiry on this report @

Geographically, the global albumin market has been segmented into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast in terms of value (USD million) and volume (kg) for each of these regions along with the CAGR for the forecast period from 2014 to 2020 have been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the report. The study also provides a list of recommendations for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Event impact analysis and clinical pipeline analysis have also been provided for albumin as an excipient in this report that will help in understanding the major events impacting the albumin market growth. Number of clinical trials also demonstrates the potential of albumin use as an excipient in pharmaceutical formulations.

Get a Free Sample Copy of the Report @

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The key players operating in the albumin market are CSL Behring LLC, HiMedia Laboratories Pvt. Ltd., InVitria, MedzBio Pte. Ltd., Mitsubishi Tanabe Pharma Corporation, Novozymes A/S, Octapharma AG, RayBiotech, Inc., Sigma-Aldrich Corporation, and Thermo Fisher Scientific.

Table Of Content

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.3.1 Sources Secondary Research Primary Research

1.3.2 Assumptions and Limitations

1.4 List of Abbreviations

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Albumin Market (2013 & 2020)

2.2 Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 & 2020 (Value %)

2.3 Global Albumin Market Volume, by Geography, 2012 – 2020 (Kilograms)

Chapter 3 Albumin Market Overview

3.1 Introduction

3.2 Market Dynamics

3.2.1 Drivers Improved product stability with albumin as an excipient leading to increase in its demand Improvements in protein purification and molecular separation technology to boost market growth Use of recombinant albumin to drive the albumin market

3.2.2 Restraints Stringent regulations, cost and health care issues are anticipated to affect the market Trend toward serum-free, specialty and customized media solutions could hamper the albumin market

3.2.3 Opportunities Expanding applications of albumin such as nanotechnology would revolutionize the albumin market, particularly recombinant albumin Focus on emerging regions to provide immense potential for the global albumin market

3.3 Porter’s Five Force Analysis for the Global Albumin Market

3.3.1 Bargaining Power of Suppliers

3.3.2 Bargaining Power of Buyers

3.3.3 Threat of Substitutes

3.3.4 Threat of New Entrants

3.3.5 Competitive Rivalry

3.4 Market Attractiveness Analysis: Global Albumin Market, by Geography

3.5 Event Impact Analysis

3.6 Clinical Pipeline Analysis

3.7 Examples of Products Containing Albumin as an Excipient